SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Momenta Pharmaceuticals, Inc. Release: First Patient Dosed With M402 in Phase 1/2 Clinical Trial in Metastatic Pancreatic Cancer